Description for KPV 10mg Peptide.

The Tiny Tripeptide Powerhouse: How a Three-Amino-Acid Fragment Tames Inflammation at Its Core

What if a minuscule, naturally derived tripeptide could slip into inflamed tissues, silence overactive inflammatory signals, accelerate mucosal healing, and restore barrier integrity—all while sidestepping the broad side effects of conventional anti-inflammatories? In laboratory models of colitis, dermatitis, and wound repair, researchers are actively uncovering exactly this potential with the KPV 10mg Peptide, the C-terminal fragment of α-melanocyte-stimulating hormone (α-MSH) that's emerging as a precision tool for probing anti-inflammatory pathways, immune modulation, and epithelial protection.

This compact Lys-Pro-Val sequence (KPV) retains much of the parent hormone's potent immunomodulatory activity without activating melanocortin receptors or triggering pigmentation changes—making it a clean, focused probe for studying NF-κB suppression, cytokine downregulation, and PepT1-mediated uptake in inflamed cells. Available in a 10mg lyophilized vial from Cali BioLab Peptides, the KPV 10mg Peptide provides ≥99% purity, third-party HPLC/MS confirmation, batch-specific COAs, and fast USA domestic shipping—delivering a reliable, high-quality reagent for qualified researchers investigating gut barrier dysfunction, chronic inflammatory states, skin repair mechanisms, and beyond.

If your studies target intestinal inflammation models (DSS/TNBS colitis, IBD analogs), wound healing assays, epithelial barrier integrity, or targeted anti-inflammatory signaling without melanocortin side effects, the KPV 10mg Peptide could be the elegant, low-molecular-weight tool that sharpens your experimental edge. Let's explore the mechanisms, real lab impact, and research advantages driving its growing interest in 2026.

Strict Disclaimer: For laboratory and scientific research use only. Not for human consumption, therapeutic, diagnostic, veterinary, or any non-research applications. Strictly intended for qualified researchers conducting in-vitro, ex-vivo, or ethically approved animal model studies. Cali BioLab Peptides maintains full regulatory compliance.

The Colitis Turnaround: Dr. Li's Murine Model That Sparked Renewed Hope

In a gastrointestinal inflammation research group at a leading East Asian university, Dr. Wei Li had been battling the limitations of standard IBD models. His DSS-induced colitis mice showed persistent weight loss, severe colonic shortening, elevated MPO activity, massive neutrophil infiltration, and skyrocketing pro-inflammatory cytokine transcripts (TNF-α, IL-1β, IL-6)—despite aggressive interventions with 5-ASA analogs or steroids.

Frustrated by incomplete mucosal healing and frequent relapses in surviving animals, Wei revisited studies on α-MSH fragments. He noted that the C-terminal tripeptide KPV demonstrated potent anti-inflammatory effects in colonic epithelial cells via PepT1 uptake—independent of melanocortin receptors. He ordered the KPV 10mg Peptide from Cali BioLab Peptides for an oral delivery protocol using hyaluronic acid-functionalized nanoparticles (inspired by published targeted systems). The 10mg vial arrived sterile and lyophilized, with COA verifying 99.3% purity and excellent solubility.

In his DSS colitis cohort, oral administration of nanoparticle-encapsulated KPV 10mg Peptide (dosed to achieve ~1-5 mg/kg effective exposure) dramatically attenuated disease: mice regained weight faster, colon lengths normalized, histological scores dropped (reduced crypt loss, ulceration, and infiltration), MPO activity plummeted, and mRNA levels of TNF-α, IL-6, and IL-1β decreased by 60-80% compared to vehicle controls. Strikingly, mucosal healing accelerated with restored tight junction proteins (ZO-1, occludin) and reduced apoptosis in epithelial layers.

Wei's publication in a high-impact gastroenterology journal positioned KPV 10mg Peptide as a promising probe for PepT1-targeted anti-inflammatory delivery in IBD models, earning collaborative offers from nanoparticle specialists and renewed funding. The peptide became a staple for his group's barrier repair and inflammation resolution studies.

What persistent inflammatory endpoint in your models might the KPV 10mg Peptide help resolve more selectively than broader agents?

What Exactly Is the KPV 10mg Peptide?

The KPV 10mg Peptide is a synthetic tripeptide (Lys-Pro-Val) representing the C-terminal residues (11-13) of α-melanocyte-stimulating hormone (α-MSH). This minimal fragment retains robust anti-inflammatory activity while eliminating melanocortin receptor activation and pigmentation effects associated with the full hormone.

Key specifications:

• Quantity: 10mg sterile lyophilized powder per vial—ideal for dose-response curves, multiple replicates, chronic protocols, or combination experiments
• Purity: ≥99% (third-party verified by HPLC and Mass Spectrometry)
• Sequence: Lys-Pro-Val (linear tripeptide; often studied as Ac-KPV-NH₂ or unmodified forms in literature)
• Molecular Formula: C₁₆H₃₀N₄O₄ (or C₁₇H₃₂N₆O₄ for acetylated/amidated variants)
• Molecular Weight: ≈342-384 Da (depending on exact form and counterions)
• Form: White, sterile lyophilized powder optimized for reconstitution and stability
• Storage: -20°C long-term; 2-8°C after reconstitution with bacteriostatic water or PBS
• COA: Full batch-specific analytical report included with every order

Mechanistically, KPV 10mg Peptide exerts potent anti-inflammatory effects primarily through inhibition of NF-κB nuclear translocation, suppression of pro-inflammatory cytokine production (TNF-α, IL-1β, IL-6), and promotion of mucosal healing via enhanced epithelial restitution and tight junction integrity. In colonic models, it is transported intracellularly via the peptide transporter PepT1 (upregulated in inflamed epithelium), enabling targeted delivery to affected cells.

Check out other popular peptides from our online store like;Retatrutide GLP-3 RT 30mg Peptide , GHK-Cu 50mg Copper Peptide , Ipamorelin 5mg Peptide.

Why Researchers Are Turning to KPV 10mg Peptide for Inflammation and Barrier Studies

KPV's appeal stems from its selectivity and versatility: it dampens excessive inflammation without broad immunosuppression, promotes healing in damaged epithelia, and exploits upregulated transporters in diseased tissue for targeted action—ideal for modeling chronic inflammatory conditions like IBD, dermatitis, or wound repair.

Preclinical highlights:

• Significant reduction in colonic inflammation scores, MPO activity, and cytokine expression in DSS/TNBS colitis models
• Accelerated mucosal healing and restoration of tight junctions in ulcerative colitis analogs
• Suppression of NF-κB signaling and pro-inflammatory mediator release in epithelial and immune cells
• Potential in PepT1-dependent delivery systems for oral or localized administration
• Complementary effects in skin inflammation, wound models, and even cancer-associated colitis prevention
• Low molecular weight enabling efficient penetration and stability in complex matrices

Sourcing from Cali BioLab Peptides ensures USA-certified manufacturing, rapid domestic shipping, secure checkout, and clear research-only framing—vital for maintaining experimental reproducibility and compliance.

How to Integrate KPV 10mg Peptide into Experimental Workflows

Reconstitution is straightforward:

1. Equilibrate vial to room temperature.
2. Add 1-2 mL bacteriostatic water or sterile PBS; gently swirl to dissolve.
3. Prepare stock solutions (e.g., 5 mg/mL) and dilute for working concentrations (typically 1-100 μM in vitro or 0.1-5 mg/kg in vivo).
4. Aliquot and freeze at -80°C for long-term storage.

Applications include:

• In-vitro epithelial cell inflammation assays (TNF-α stimulation, cytokine ELISAs)
• DSS/TNBS colitis models (oral, intraperitoneal, or targeted delivery)
• Wound healing scratch assays or 3D skin equivalents
• PepT1 uptake and NF-κB pathway studies (Western blot, qPCR)

Always employ sterile technique and ethical protocols.

Advantages of KPV 10mg Peptide – A Researcher's Essential List

• Potent NF-κB inhibition and cytokine suppression in inflamed models
• PepT1-mediated targeted uptake in diseased epithelium
• Promotion of mucosal barrier repair and tight junction integrity
• Minimal melanocortin receptor activation (no pigmentation effects)
• High purity and batch transparency for reliable results
• 10mg vial size supporting acute through chronic studies
• Excellent stability and solubility in standard buffers
• USA-sourced, fast shipping, dedicated researcher support
• Strict research-only compliance for grant/IRB alignment

Frequently Asked Questions About KPV 10mg Peptide

Q: How does KPV differ from full-length α-MSH in research models? A: KPV retains core anti-inflammatory activity but lacks melanocortin receptor binding, eliminating pigmentation and other MSH-related effects.

Q: What dosing ranges are common in preclinical literature? A: In-vivo studies often use 0.1-5 mg/kg (oral, IP, or targeted); in-vitro concentrations typically 1-100 μM.

Q: Is KPV stable for oral delivery models? A: Yes—its small size and stability support oral administration, especially in nanoparticle or PepT1-targeted formats.

Q: Suitable for skin or wound healing models? A: Yes—preclinical data show benefits in dermatitis analogs and epithelial repair assays.

Q: Stability post-reconstitution? A: Stable for weeks refrigerated; freeze aliquots for longer storage.

Q: How to verify batch quality? A: Match the provided COA details on the product page.

What Inflammatory or Barrier Question Could KPV 10mg Peptide Help You Answer?

With rising focus on targeted mucosal therapies and inflammation resolution, what specific cytokine pathway, epithelial defect, or delivery challenge might the KPV 10mg Peptide illuminate in your research? Could it refine your IBD models or uncover new synergies?

Share your thoughts—the scientific exchange drives discovery.

In summary, the KPV 10mg Peptide from Cali BioLab Peptides is a compact, potent probe for anti-inflammatory and healing mechanisms. With superior purity, reliable supply, and proven utility in gut, skin, and immune models, it's primed to accelerate your 2026 investigations.

Order your KPV 10mg Peptide today at https://www.calibiolabpeptides.com/ and target inflammation with precision.